Does Smoking Status Affect Survival After Chemoradiotherapy for Locally Advanced Non-SmallCell Lung Cancer?

被引:0
|
作者
Wallace, N. D. [1 ]
Alexander, M. [1 ]
Xie, S. [1 ]
Ball, D. [1 ]
Solomon, B. [1 ]
Plumridge, N. [1 ]
Shaw, M. [1 ]
Harden, S. [1 ]
Hegi-Johnson, F. [1 ]
Siva, S. [1 ]
John, T. [1 ]
Officer, A. [1 ]
MacManus, M. [1 ]
机构
[1] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
关键词
Smoking Status; NSCLC; Chemoradiotherapy;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MA03.03
引用
收藏
页码:S105 / S106
页数:2
相关论文
共 50 条
  • [1] The impact of pre-treatment smoking status on survival after chemoradiotherapy for locally advanced non-small-cell lung cancer
    Wallace, Neil D.
    Alexander, Marliese
    Xie, Jing
    Ball, David
    Hegi-Johnson, Fiona
    Plumridge, Nikki
    Siva, Shankar
    Shaw, Mark
    Harden, Susan
    John, Tom
    Solomon, Ben
    Officer, Ann
    MacManus, Michael
    LUNG CANCER, 2024, 190
  • [2] Long-Term Prognosis of Patients Undergoing Trimodality Therapy for Locally Advanced Non-SmallCell Lung Cancer
    Okada, K.
    Suzawa, K.
    Ryuko, T.
    Tomioka, Y.
    Tanaka, S.
    Shien, K.
    Miyoshi, K.
    Okazaki, M.
    Sugimoto, S.
    Suzuki, E.
    Soh, J.
    Toyooka, S.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S574 - S574
  • [3] Predictive factors associated with prolonged survival in patients with advanced non-smallcell lung cancer (NSCLC) treated with gefitinib
    Satouchi, Miyako
    Funada, Yasuhiro
    Urata, Yoshiko
    Shimada, Temiko
    Yoshimura, Sho
    Watanabe, Hirokazu
    Kurata, Takayasu
    Adachi, Shuji
    Takada, Yoshiki
    Negoro, Shunichi
    ANNALS OF ONCOLOGY, 2006, 17 : 231 - 231
  • [4] Atezolizumab in previously treated non-smallcell lung cancer patients
    Serino, Mariana
    Santos, Vanessa
    Araujo, David
    Novais-Bastos, Helder
    Magalhaes, Adriana
    Fernandes, Gabriela
    Queiroga, Henrique
    Hespanhol, Venceslau
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [5] Proteomics-based phenotypic classification of non-smallcell lung cancer
    Berkovska, O.
    Mermelekas, G.
    Orre, L.
    Lehtio, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S1163 - S1164
  • [6] Prognostic significance of K-ras point mutations in the serum of patients with advanced non-smallcell lung cancer
    Sirera, R
    Bayo, P
    Martin, M
    Safont, MJ
    Blasco, A
    Caballero, C
    Garde, J
    Berrocal, A
    Ponce, R
    Camps, C
    LUNG CANCER, 2004, 45 : S28 - S28
  • [7] Clinical Features and Prognostic Factors in Elderly Koreans with Advanced Non-SmallCell Lung Cancer in a Tertiary Referral Hospital
    Kim, Seo Woo
    Kim, Mi Yeon
    Lee, Yoon Pyo
    Ryu, Yon Ju
    Lee, Seok Jeong
    Lee, Jin Hwa
    Chang, Jung Hyun
    Shim, Sung Shine
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2013, 75 (02) : 52 - 58
  • [8] FoxM1 mediated resistance to gefitinib in non-smallcell lung cancer cells
    Nuo Xu
    Xin Zhang
    Xun Wang
    Hai-yan Ge
    Xiao-ying Wang
    David Garfield
    Ping Yang
    Yuan-lin Song
    Chun-xue Bai
    Acta Pharmacologica Sinica, 2012, 33 : 675 - 681
  • [9] Impact of interstitial lung abnormality on survival after adjuvant durvalumab with chemoradiotherapy for locally advanced non-small cell lung cancer
    Kashihara, Tairo
    Nakayama, Yuko
    Okuma, Kae
    Takahashi, Ayaka
    Kaneda, Tomoya
    Katagiri, Mika
    Nakayama, Hiroki
    Kubo, Yuko
    Ito, Kimiteru
    Nakamura, Satoshi
    Takahashi, Kana
    Inaba, Koji
    Murakami, Naoya
    Saito, Tetsuo
    Okamoto, Hiroyuki
    Itami, Jun
    Kusumoto, Masahiko
    Ohe, Yuichiro
    Igaki, Hiroshi
    RADIOTHERAPY AND ONCOLOGY, 2023, 180
  • [10] Radical Lung Resection after Curative Chemoradiotherapy for Locally Advanced Lung Cancer
    Yamashita, Motohiro
    Ueno, Tsuyashi
    Suehisa, Hiroshi
    Sawada, Sihigeki
    Kitajima, Hiromoto
    Harada, Daijiro
    Kohzuki, Toshiyuki
    Nogami, Naoyuki
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S572 - S572